Merck & Company Inc (MRK) stock news · P/E 116, rev $65.01B
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
This MRK news page leads with what Merck & Company Inc filed — not a scraped headline mill.
No cached 8-K sentence for MRK yet. We will not pad this page with generic market recap.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 116.2.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MRK stock page; for the tape open the quote page.
MRK stock news FAQ
What are MRK's latest revenue and net income?
Latest cached Merck & Company Inc (MRK) revenue for Dec 31, 2025 was $65.01B. Net income was $18.25B. Statements: https://lician.com/financials/mrk
How did MRK revenue change from the prior cached period?
Cached Merck & Company Inc (MRK) revenue was up 1.3% from $64.17B (Dec 31, 2024) to $65.01B (Dec 31, 2025). Statements: https://lician.com/financials/mrk
What is MRK's P/E ratio?
Merck & Company Inc (MRK) trailing P/E is 116.2 on the latest cached fundamentals snapshot.
What is MRK's market cap?
Merck & Company Inc (MRK) market cap is $285.12B on the latest cached fundamentals snapshot.
What kind of company is MRK?
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE.
Where is MRK stock news listed?
Cached stock news for Merck & Company Inc (MRK) is listed at https://lician.com/news/mrk. Filings: https://lician.com/sec/mrk
Not investment advice.